dexamethasone cyclodextrin nanoparticle ophthalmic suspension (OCS-01) - Oculis
LEOPARD: Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema (clinicaltrials.gov) - Nov 8, 2022 - P2 | N=24 | Not yet recruiting | Sponsor: Quan Dong Nguyen 
New P2 trial • Macular Edema • Ocular Inflammation • Ophthalmology • Uveitis
http://clinicaltrials.gov/ct2/show/NCT05608837
 
Nov 8, 2022
 
Prev Next